Correlation Between Cardiol Therapeutics and PHN Multi

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardiol Therapeutics and PHN Multi at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiol Therapeutics and PHN Multi into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiol Therapeutics Class and PHN Multi Style All Cap, you can compare the effects of market volatilities on Cardiol Therapeutics and PHN Multi and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiol Therapeutics with a short position of PHN Multi. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiol Therapeutics and PHN Multi.

Diversification Opportunities for Cardiol Therapeutics and PHN Multi

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cardiol and PHN is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and PHN Multi Style All Cap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PHN Multi Style and Cardiol Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiol Therapeutics Class are associated (or correlated) with PHN Multi. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PHN Multi Style has no effect on the direction of Cardiol Therapeutics i.e., Cardiol Therapeutics and PHN Multi go up and down completely randomly.

Pair Corralation between Cardiol Therapeutics and PHN Multi

Assuming the 90 days trading horizon Cardiol Therapeutics Class is expected to under-perform the PHN Multi. In addition to that, Cardiol Therapeutics is 3.84 times more volatile than PHN Multi Style All Cap. It trades about -0.21 of its total potential returns per unit of risk. PHN Multi Style All Cap is currently generating about 0.13 per unit of volatility. If you would invest  2,758  in PHN Multi Style All Cap on August 28, 2024 and sell it today you would earn a total of  67.00  from holding PHN Multi Style All Cap or generate 2.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cardiol Therapeutics Class  vs.  PHN Multi Style All Cap

 Performance 
       Timeline  
Cardiol Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
PHN Multi Style 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in PHN Multi Style All Cap are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of very unfluctuating basic indicators, PHN Multi may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Cardiol Therapeutics and PHN Multi Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardiol Therapeutics and PHN Multi

The main advantage of trading using opposite Cardiol Therapeutics and PHN Multi positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiol Therapeutics position performs unexpectedly, PHN Multi can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PHN Multi will offset losses from the drop in PHN Multi's long position.
The idea behind Cardiol Therapeutics Class and PHN Multi Style All Cap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like